HK1231395A1 - 生物活性血紅素過氧化物酶組合物和使用方法 - Google Patents

生物活性血紅素過氧化物酶組合物和使用方法

Info

Publication number
HK1231395A1
HK1231395A1 HK17105151.5A HK17105151A HK1231395A1 HK 1231395 A1 HK1231395 A1 HK 1231395A1 HK 17105151 A HK17105151 A HK 17105151A HK 1231395 A1 HK1231395 A1 HK 1231395A1
Authority
HK
Hong Kong
Prior art keywords
methods
heme
bioactive
haloperoxidase
compositions
Prior art date
Application number
HK17105151.5A
Other languages
English (en)
Inventor
Jr Jackson T Stephens
Matthew J Pete
Original Assignee
Exoxemis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exoxemis Inc filed Critical Exoxemis Inc
Publication of HK1231395A1 publication Critical patent/HK1231395A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/08—Amines; Quaternary ammonium compounds containing oxygen or sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
HK17105151.5A 2014-01-14 2017-05-22 生物活性血紅素過氧化物酶組合物和使用方法 HK1231395A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927406P 2014-01-14 2014-01-14
US14/593,648 US9814234B2 (en) 2014-01-14 2015-01-09 Bioactive heme-haloperoxidase compositions and methods of their use
PCT/US2015/011435 WO2015108999A1 (en) 2014-01-14 2015-01-14 Bioactive heme-haloperoxidase compositions and methods of their use

Publications (1)

Publication Number Publication Date
HK1231395A1 true HK1231395A1 (zh) 2017-12-22

Family

ID=53520188

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105151.5A HK1231395A1 (zh) 2014-01-14 2017-05-22 生物活性血紅素過氧化物酶組合物和使用方法

Country Status (10)

Country Link
US (1) US9814234B2 (zh)
EP (1) EP3094319A4 (zh)
JP (1) JP2017502093A (zh)
CN (1) CN105916497A (zh)
AU (1) AU2015206516A1 (zh)
CA (1) CA2936105A1 (zh)
HK (1) HK1231395A1 (zh)
IL (1) IL246711A0 (zh)
MX (1) MX2016009094A (zh)
WO (1) WO2015108999A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019302744A1 (en) * 2018-07-13 2021-02-04 Robert C. Allen Haloperoxidase compositions and uses thereof
GB2589863A (en) * 2019-12-09 2021-06-16 Institute Of Tech Sligo Antimicrobial composition
WO2024017883A1 (en) * 2022-07-18 2024-01-25 Acies Bio D.O.O. Peroxidase based biocontrol agents
WO2024105146A1 (en) 2022-11-16 2024-05-23 Flen Health Pharma Nv Peroxidase compositions containing improved enhancing agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389369A (en) 1991-02-21 1995-02-14 Exoxemis, Inc. Halo peroxidase containing compositions for killing yeast and sporular microorganisms
US5888505A (en) * 1991-02-21 1999-03-30 Eoe, Inc. Method for selectively inhibiting the growth of microbes using a haloperoxidase-halide-peroxide system
JP4063317B2 (ja) 1991-02-21 2008-03-19 エクソゼミス，インコーポレイテッド 感染治療および叢制御の方法および組成物
EP1003376B1 (en) 1997-08-14 2003-07-02 Novozymes A/S Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source
WO2002047483A1 (en) 2000-12-15 2002-06-20 Novozymes A/S Use of haloperoxidase, peroxide and carboxylic acid
US6855328B2 (en) 2002-03-28 2005-02-15 Ecolab Inc. Antimicrobial and antiviral compositions containing an oxidizing species
KR101497285B1 (ko) * 2005-08-26 2015-02-27 허큘레스 인코포레이티드 상승작용성 살생물제 및 미생물 성장 억제를 위한 방법
US20080114054A1 (en) 2006-11-14 2008-05-15 Rath Microbes Compositions and methods for reducing antimicrobial resistance of microbes
US8945540B2 (en) 2008-05-09 2015-02-03 Exoxemis, Inc. Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
WO2013009910A2 (en) 2011-07-11 2013-01-17 Exoxemis, Inc. Eosinophil peroxidase compositions and methods of their use

Also Published As

Publication number Publication date
EP3094319A4 (en) 2017-06-28
AU2015206516A1 (en) 2016-08-18
CA2936105A1 (en) 2015-07-23
US9814234B2 (en) 2017-11-14
US20150196025A1 (en) 2015-07-16
WO2015108999A1 (en) 2015-07-23
EP3094319A1 (en) 2016-11-23
MX2016009094A (es) 2016-09-09
WO2015108999A8 (en) 2016-08-11
CN105916497A (zh) 2016-08-31
IL246711A0 (en) 2016-08-31
JP2017502093A (ja) 2017-01-19

Similar Documents

Publication Publication Date Title
HRP20192145T1 (hr) Pripravci nosača-antitijela i metode pripreme i uporabe istih
IL250415B (en) Antibodies against pd-l and methods of using them
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
ZA201701909B (en) Trichoderma compositions and methods of use
IL280690A (en) Pharmaceutical preparations that include DGLA and their use
IL248160A0 (en) Compositions of tissue fillers and methods of use
EP3190886A4 (en) Compositions and methods of use thereof
IL256843B (en) Cleaning products and methods of using them
HK1252057A1 (zh) 新穎的使用方法和組合物
ZA201606450B (en) Compounds and their methods of use
HK1231395A1 (zh) 生物活性血紅素過氧化物酶組合物和使用方法
HK1243404A1 (zh) 色酰胺組合物和使用方法
IL261794A (en) Preparations and methods for using them
GB2537518B (en) Settable compositions and methods of use
GB201402915D0 (en) Compositions and methods
GB201419559D0 (en) Therapeutic compositions and methods
AU2014905067A0 (en) Compositions and methods of use
GB201418410D0 (en) use of compositions of matter
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
AU2014902829A0 (en) Compositions and Methods of Use
GB201403212D0 (en) Compositions and methods